117 related articles for article (PubMed ID: 19930157)
21. Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549.
Yu Q; Su B; Liu D; Liu B; Fan Y; Wang Y; Meng X
Oligonucleotides; 2007; 17(3):327-35. PubMed ID: 17854272
[TBL] [Abstract][Full Text] [Related]
22. Anti-proliferation effect of BMI-1 in U937 cells with siRNA.
Zhu W; Huang L; Xu X; Qian H; Xu W
Int J Mol Med; 2010 Jun; 25(6):889-95. PubMed ID: 20428793
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma.
Wu Z; Min L; Chen D; Hao D; Duan Y; Qiu G; Wang Y
PLoS One; 2011 Feb; 6(2):e14648. PubMed ID: 21311599
[TBL] [Abstract][Full Text] [Related]
24. Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis.
Wiederschain D; Chen L; Johnson B; Bettano K; Jackson D; Taraszka J; Wang YK; Jones MD; Morrissey M; Deeds J; Mosher R; Fordjour P; Lengauer C; Benson JD
Mol Cell Biol; 2007 Jul; 27(13):4968-79. PubMed ID: 17452456
[TBL] [Abstract][Full Text] [Related]
25. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.
Li J; Gong LY; Song LB; Jiang LL; Liu LP; Wu J; Yuan J; Cai JC; He M; Wang L; Zeng M; Cheng SY; Li M
Am J Pathol; 2010 Feb; 176(2):699-709. PubMed ID: 20035051
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between MTA1 expression and invasive and metastatic ability of cervical cancer cell].
Han XY; Qian HL; Yang JJ; Zhang XY; Fu M; Liang X; Lin C; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):678-83. PubMed ID: 22176993
[TBL] [Abstract][Full Text] [Related]
27. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
[TBL] [Abstract][Full Text] [Related]
28. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.
Li Y; Tian Z; Tan Y; Lian G; Chen S; Chen S; Li J; Li X; Huang K; Chen Y
Mol Cancer; 2020 Jun; 19(1):109. PubMed ID: 32580736
[TBL] [Abstract][Full Text] [Related]
29. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression.
Douglas D; Hsu JH; Hung L; Cooper A; Abdueva D; van Doorninck J; Peng G; Shimada H; Triche TJ; Lawlor ER
Cancer Res; 2008 Aug; 68(16):6507-15. PubMed ID: 18701473
[TBL] [Abstract][Full Text] [Related]
30. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG
FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
32. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins.
Guo WJ; Datta S; Band V; Dimri GP
Mol Biol Cell; 2007 Feb; 18(2):536-46. PubMed ID: 17151361
[TBL] [Abstract][Full Text] [Related]
33. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
[TBL] [Abstract][Full Text] [Related]
34. Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells.
Wang Q; Li WL; You P; Su J; Zhu MH; Xie DF; Zhu HY; He ZY; Li JX; Ding XY; Wang X; Hu YP
J Cell Biochem; 2009 Jan; 106(1):16-24. PubMed ID: 19021148
[TBL] [Abstract][Full Text] [Related]
35. Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells.
Xu XH; Liu Y; Li DJ; Hu J; Su J; Huang Q; Lu MQ; Yi F; Bao D; Fu YZ
Technol Cancer Res Treat; 2016 Oct; 15(5):NP27-39. PubMed ID: 26294655
[TBL] [Abstract][Full Text] [Related]
36. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
Rao Y; Wang H; Fan L; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
[TBL] [Abstract][Full Text] [Related]
37. HDAC inhibitors conquer Polycomb proteins.
Yaswen P
Cell Cycle; 2010 Jul; 9(14):2705. PubMed ID: 20676029
[No Abstract] [Full Text] [Related]
38. [Adenovirus-delivered BMI-1 shRNA].
Chen ZP; Chen XL; Zhen J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1278-82. PubMed ID: 19840467
[TBL] [Abstract][Full Text] [Related]
39. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
Fan C; Liu J; Tian J; Zhang Y; Yan M; Zhu C
Cytogenet Genome Res; 2018; 154(4):209-216. PubMed ID: 29902801
[TBL] [Abstract][Full Text] [Related]
40. Collagen I regulates the self-renewal of mouse embryonic stem cells through α2β1 integrin- and DDR1-dependent Bmi-1.
Suh HN; Han HJ
J Cell Physiol; 2011 Dec; 226(12):3422-32. PubMed ID: 21344393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
